SPRB · NASDAQ · Biotechnology

Spruce Biosciences (SPRB)

Develops an enzyme therapy for Sanfilippo syndrome and a preclinical CAH antibody.

$48.63
vs last close−1.36 (−2.72%)

13F · 13D/G · Form 4

Institutions70.00%2.01M shares
65 holders · as of Jun 30, 2026
Insiders1.08%30.9K shares
4 holders · as of Jul 9, 2026
Strategic holders0.04%1.1K shares
1 holder · as of Oct 8, 2025
Other28.88%830.2K shares
remainder

2.87M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Aigh Capital Management LLCInstitution
8.70%250,000as of Jun 30, 2026
Orbimed Advisors LLCInstitution
6.96%200,000as of Jun 30, 2026
BlackRock, Inc.Institution
6.54%187,836as of Jun 30, 2026
Millennium Management LLCInstitution
5.60%160,981as of Jun 30, 2026
AWM Investment Company, Inc.Institution
5.11%146,988filed Aug 14, 2026
Ikarian Capital, LLCInstitution
4.22%121,356as of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.15%119,331as of Jun 30, 2026
Alyeska Investment Group, L.P.Institution
2.84%81,671as of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.45%70,548as of Jun 30, 2026
Adar1 Capital Management, LLCInstitution
2.36%67,717as of Jun 30, 2026
Cable Car Capital LLCInstitution
2.09%60,000as of Jun 30, 2026
Citadel Advisors LLCInstitution
1.81%51,905as of Jun 30, 2026
State Street CorpInstitution
1.76%50,450as of Jun 30, 2026
Boothbay Fund Management, LLCInstitution
1.46%42,080as of Jun 30, 2026
Stempoint Capital LPInstitution
1.44%41,388as of Jun 30, 2026
Eversept Partners, LPInstitution
1.39%40,000as of Jun 30, 2026
Carlyle Group Inc.Institution
1.34%38,620as of Jun 30, 2026
Goldman Sachs Group IncInstitution
1.13%32,348as of Jun 30, 2026
Affinity Asset Advisors, LLCInstitution
1.04%30,000as of Jun 30, 2026
Diadema Partners LPInstitution
1.04%30,000as of Jun 30, 2026
Stonepine Capital Management, LLCInstitution
1.00%28,795as of Jun 30, 2026
Point72 Asset Management, L.P.Institution
0.98%28,278as of Jun 30, 2026
Quinn Opportunity Partners LLCInstitution
0.93%26,810as of Jun 30, 2026
UBS Group AGInstitution
0.81%23,381as of Jun 30, 2026
Exoduspoint Capital Management, LPInstitution
0.77%22,000as of Jun 30, 2026

13F, as of Jun 30, 2026

65 holders · 2.01M shares · 37 new positions · 53 increased · 3 reduced · 4 closed

HolderShares% outstandingChg q/qFiled
Aigh Capital Management LLC250.0K8.70%+250.0KnewAug 7, 2026
Orbimed Advisors LLC200.0K6.96%+200.0KnewAug 14, 2026
BlackRock, Inc.187.8K6.54%+170.9KAug 7, 2026
Millennium Management LLC161.0K5.60%+49.1KAug 14, 2026
Ikarian Capital, LLC121.4K4.22%0Aug 14, 2026
Vanguard Capital Management LLC119.3K4.15%+101.0KAug 13, 2026
Alyeska Investment Group, L.P.81.7K2.84%+30.0KAug 14, 2026
Geode Capital Management, LLC70.5K2.45%+57.7KAug 12, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Integrated Core Strategies (US) LLC9.60%103.0K13GFeb 24, 2026
Orin Hirschman9.10%250.0K13GJul 27, 2026
BlackRock, Inc.6.80%187.8K13GJul 30, 2026
Boone Peter David Mr6.40%68.2K13GNov 24, 2025
ADAR1 Capital Management, LLC5.40%58.0K13GFeb 17, 2026
AWM Investment Company, Inc.5.10%147.0K13GAug 14, 2026
Citadel Advisors LLC5.10%70.0K13GMay 15, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Oct 6, 2025
Parkman Healthcare Partners LLC10 percent owner
Sale · 2 lots257$19.141,050
Oct 6, 2025
Parkman Healthcare Partners LLC10 percent owner
Purchase256$17.911,307

House and Senate disclosures

Not reported.